Publications

2023

• Early cellular and molecular signatures correlate with severity of West Nile virus infectionLee H, Zhao Y, Fleming I, Mehta S, Wang X, Wyk B, Ronca S, Kang H, Chou C, Fatou B, Smolen K, Levy O, Clish C, Xavier R, Steen H, Hafler D, Love J, Shalek A, Guan L, Murray K, Kleinstein S, Montgomery R. Early cellular and molecular signatures correlate with severity of West Nile virus infection. IScience 2023, 26: 108387. DOI: 10.1016/j.isci.2023.108387.
• Cartilage tissues regulate systemic aging via ectonucleotide pyrophosphatase/phosphodiesterase 1 in mice.Arima T, Sugimoto K, Taniwaki T, Maeda K, Shibata Y, Tateyama M, Karasugi T, Tokunaga T, Sueyoshi T, Hisanaga S, Masuda T, Uehara Y, Yugami M, Matsushita K, Yonemitsu R, Kawakami J, Yoshimura N, Tanimura S, Kato H, Ito N, Inoue K, Bando K, Nakamura T, Miyamoto T. Cartilage tissues regulate systemic aging via ectonucleotide pyrophosphatase/phosphodiesterase 1 in mice. J Biol Chem 2023, 105512. PMID: 38042486, DOI: 10.1016/j.jbc.2023.105512.
• A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily betterDjureinovic D, Weiss S, Krykbaeva I, Qu R, Vathiotis I, Moutafi M, Zhang L, Perdigoto A, Wei W, Anderson G, Damsky W, Hurwitz M, Johnson B, Schoenfeld D, Mahajan A, Hsu F, Miller-Jensen K, Kluger Y, Sznol M, Kaech S, Bosenberg M, Jilaveanu L, Kluger H. A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better. Molecular Cancer 2023, 22: 182. PMID: 37964379, PMCID: PMC10644655, DOI: 10.1186/s12943-023-01884-x.
• Extracellular Macrophage Migration Inhibitory Factor (MIF) Downregulates Adipose Hormone-Sensitive Lipase (HSL) and Contributes to ObesityChen L, Li L, Cui D, Huang Y, Tong H, Zabihi H, Wang S, Qi Y, Lakowski T, Leng L, Liu S, Wu H, Young L, Bucala R, Qi D. Extracellular Macrophage Migration Inhibitory Factor (MIF) Downregulates Adipose Hormone-Sensitive Lipase (HSL) and Contributes to Obesity. Molecular Metabolism 2023, 101834. PMID: 37935315, DOI: 10.1016/j.molmet.2023.101834.
• Causal identification of single-cell experimental perturbation effects with CINEMA-OTDong M, Wang B, Wei J, de O. Fonseca A, Perry C, Frey A, Ouerghi F, Foxman E, Ishizuka J, Dhodapkar R, van Dijk D. Causal identification of single-cell experimental perturbation effects with CINEMA-OT. Nature Methods 2023, 20: 1769-1779. PMID: 37919419, PMCID: PMC10630139, DOI: 10.1038/s41592-023-02040-5.
• Severity of Coexisting Diabetic Glomerular Lesions Affects Outcomes in Primary Glomerular DiseasePerincheri S. Severity of Coexisting Diabetic Glomerular Lesions Affects Outcomes in Primary Glomerular Disease. Kidney360 2023, 4: 1345-1346. PMID: 37883998, PMCID: PMC10617791, DOI: 10.34067/kid.0000000000000267.
• ENPP1 in Blood and Bone: Skeletal and Soft Tissue Diseases Induced by ENPP1 DeficiencyFerreira C, Carpenter T, Braddock D. ENPP1 in Blood and Bone: Skeletal and Soft Tissue Diseases Induced by ENPP1 Deficiency. Annual Review Of Pathology Mechanisms Of Disease 2023, 19 PMID: 37871131, DOI: 10.1146/annurev-pathmechdis-051222-121126.
• Microfluidic Immuno‐Serolomic Assay Reveals Systems Level Association with COVID‐19 Pathology and Vaccine Protection (Small Methods 10/2023)Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, Kwan J, Buitrago‐Pocasangre N, Lele N, Asashima H, Racke M, Wilson J, Givens T, Tomayko M, Schulz W, Longbrake E, Hafler D, Halene S, Fan R. Microfluidic Immuno‐Serolomic Assay Reveals Systems Level Association with COVID‐19 Pathology and Vaccine Protection (Small Methods 10/2023). Small Methods 2023, 7 DOI: 10.1002/smtd.202370057.
• Associations between ichthyosis and mood disorders: a case-control study in the All of Us research programChen G, Goldust M, Choate K, Cohen J. Associations between ichthyosis and mood disorders: a case-control study in the All of Us research program. Journal Of The American Academy Of Dermatology 2023 PMID: 37863200, DOI: 10.1016/j.jaad.2023.10.025.
• Profilin1 is required to prevent mitotic catastrophe in murine and human glomerular diseasesTian X, Pedigo C, Li K, Ma X, Bunda P, Pell J, Lek A, Gu J, Zhang Y, Rangel P, Li W, Schwartze E, Nagata S, Lerner G, Perincheri S, Priyadarshini A, Zhao H, Lek M, Menon M, Fu R, Ishibe S. Profilin1 is required to prevent mitotic catastrophe in murine and human glomerular diseases. Journal Of Clinical Investigation 2023 PMID: 37847555, DOI: 10.1172/jci171237.
• Proteome Analysis for Inflammation Related to Acute and Convalescent InfectionSigdel T, Sur S, Boada P, McDermott S, Arlehamn C, Murray K, Bockenstedt L, Kerwin M, Reed E, Harris E, Stuart K, Peters B, Sesma A, Montgomery R, Sarwal M. Proteome Analysis for Inflammation Related to Acute and Convalescent Infection. Inflammation 2023, 1-17. PMID: 37831367, DOI: 10.1007/s10753-023-01913-3.
• Machine learning analysis of pre-treatment skin biopsies predicts non-response to dupilumab in patients with eczematous dermatitisMurphy M, Hwang E, Singh K, Lee T, Cohen J, Damsky W. Machine learning analysis of pre-treatment skin biopsies predicts non-response to dupilumab in patients with eczematous dermatitis. British Journal Of Dermatology 2023, ljad389. PMID: 37818837, DOI: 10.1093/bjd/ljad389.
• Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulationLyu F, Burzynski C, Fang Y, Tal A, Chen A, Kisa J, Agrawal K, Kluger Y, Taylor H, Tal R. Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation. JCI Insight 2023 PMID: 37815869, DOI: 10.1172/jci.insight.172216.
• Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and BeyondLozar T, Laklouk I, Golfinos A, Gavrielatou N, Xu J, Flynn C, Keske A, Yu M, Bruce J, Wang W, Kuhar C, Bailey H, Harari P, Dinh H, Rimm D, Hu R, Lambert P, Fitzpatrick M. Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond. Cancers 2023, 15: 4905. PMID: 37835599, PMCID: PMC10571921, DOI: 10.3390/cancers15194905.
• Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung CancerStockhammer P, Grant M, Wurtz A, Foggetti G, Expósito F, Gu J, Zhao H, Choi J, Chung S, Li F, Walther Z, Dietz J, Duffield E, Gettinger S, Politi K, Goldberg S. Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer. Journal Of Thoracic Oncology 2023 PMID: 37806385, DOI: 10.1016/j.jtho.2023.10.001.
• A Rare Case of Methotrexate-Associated Lymphoproliferative Disease in the Orbit.Spadaro J, Perzia B, Perincheri S, Habib L. A Rare Case of Methotrexate-Associated Lymphoproliferative Disease in the Orbit. Ophthalmic Plastic And Reconstructive Surgery 2023 PMID: 37791841, DOI: 10.1097/iop.0000000000002528.
• Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literatureMogica J, Tang H, Liang Y, Zhong M, Hui P, Harigopal M, Krishnamurti U, Fischbach N, Zhan H. Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature. The Breast 2023, 72: 103586. PMID: 37812963, PMCID: PMC10568274, DOI: 10.1016/j.breast.2023.103586.
• 1434P Machine learning features derived from spatial interaction of immune cell families are associated with survival in NSCLC patients post-immunotherapyArabyarmohammadi S, Corredor G, de Rodas Gregorio M, Schalper K, Madabhushi A. 1434P Machine learning features derived from spatial interaction of immune cell families are associated with survival in NSCLC patients post-immunotherapy. Annals Of Oncology 2023, 34: s816. DOI: 10.1016/j.annonc.2023.09.2465.
• Triangular Analysis of Geographical Interplay of Lymphocytes (TriAnGIL): Predicting Immunotherapy Response in Lung CancerArabyarmohammadi S, Corredor G, Zhou Y, López de Rodas M, Schalper K, Madabhushi A. Triangular Analysis of Geographical Interplay of Lymphocytes (TriAnGIL): Predicting Immunotherapy Response in Lung Cancer. 2023, 14225: 797-807. DOI: 10.1007/978-3-031-43987-2_77.
• 361 Chronic lung inflammation abrogates quiescent state of hematopoietic stem cells in a cystic fibrosis mouse modelBraga C, Mancuso R, Thompson E, Oez H, Gudneppanavar R, Zhang P, Huang P, Murray T, Egan M, Krause D, Bruscia E. 361 Chronic lung inflammation abrogates quiescent state of hematopoietic stem cells in a cystic fibrosis mouse model. Journal Of Cystic Fibrosis 2023, 22: s183. DOI: 10.1016/s1569-1993(23)01288-2.
• 220 Ezrin is required to maintain the number and function of tissue resident alveolar macrophages in cystic fibrosis during infectionGudneppanavar R, Di Pietro C, Oez H, Zhang P, Huang P, Britto-Leon C, Krause D, Egan M, Murray T, Bruscia E. 220 Ezrin is required to maintain the number and function of tissue resident alveolar macrophages in cystic fibrosis during infection. Journal Of Cystic Fibrosis 2023, 22: s113. DOI: 10.1016/s1569-1993(23)01150-5.
• 1101P The effect of LNS8801 in combination with pembrolizumab in patients with treatment-refractory cutaneous melanomaRodon J, Chaney M, Cohen J, Garyantes T, Ishizuka J, Lin J, Lorusso P, Mita A, Mita M, Muller C, Natale C, Orloff M, Papadopoulos K, Patel S, Shoushtari A. 1101P The effect of LNS8801 in combination with pembrolizumab in patients with treatment-refractory cutaneous melanoma. Annals Of Oncology 2023, 34: s663. DOI: 10.1016/j.annonc.2023.09.2235.
• 1892P A pooled meta-analysis of salvage nivolumab/ipilimumab (N+I) after nivolumab (N) in patients with advanced renal cell carcinoma (RCC)McKay R, Xie W, Leucht K, Jegede O, Braun D, Atkins M, Grimm M, Choueiri T. 1892P A pooled meta-analysis of salvage nivolumab/ipilimumab (N+I) after nivolumab (N) in patients with advanced renal cell carcinoma (RCC). Annals Of Oncology 2023, 34: s1017-s1018. DOI: 10.1016/j.annonc.2023.09.1122.
• 1891P Determinants of exceptional response to immune checkpoint inhibition in metastatic clear cell renal cell carcinomaSaliby R, Jammihal T, Labaki C, Soulati H, Gallegos J, Peris A, McCurry D, Yu C, Shah V, Poduval D, Zarif T, Ahmar N, Laimon Y, Heng D, Signoretti S, Van Allen E, Choueiri T, Shukla S, Braun D. 1891P Determinants of exceptional response to immune checkpoint inhibition in metastatic clear cell renal cell carcinoma. Annals Of Oncology 2023, 34: s1017. DOI: 10.1016/j.annonc.2023.09.1121.
• Treatment options for necrobiosis lipoidica: a systematic reviewNihal A, Caplan A, Rosenbach M, Damsky W, Mangold A, Shields B. Treatment options for necrobiosis lipoidica: a systematic review. International Journal Of Dermatology 2023 PMID: 37772666, DOI: 10.1111/ijd.16856.
• Systematic bioprospection for cellulolytic actinomycetes in the Chihuahuan Desert: isolation and enzymatic profiling.Escudero-Agudelo J, Martínez-Villalobos J, Arocha-Garza H, Galán-Wong LJ, Avilés-Arnaut H, De la Torre-Zavala S. Systematic bioprospection for cellulolytic actinomycetes in the Chihuahuan Desert: isolation and enzymatic profiling. PeerJ 2023, 11: e16119. PMID: 37790635, DOI: 10.7717/peerj.16119.
• IRF8 in Conjunction With CD123 and CD20 to Distinguish Lupus Erythematosus Panniculitis From Subcutaneous Panniculitis-like T-Cell Lymphoma.Wong J, Roy S, McNiff J, Xu M. IRF8 in Conjunction With CD123 and CD20 to Distinguish Lupus Erythematosus Panniculitis From Subcutaneous Panniculitis-like T-Cell Lymphoma. The American Journal Of Surgical Pathology 2023 PMID: 37767989, DOI: 10.1097/pas.0000000000002133.
• Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapyMartinez-Morilla S, Moutafi M, Fernandez A, Jessel S, Divakar P, Wong P, Garcia-Milian R, Schalper K, Kluger H, Rimm D. Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy. OncoImmunology 2023, 12: 2260618. PMID: 37781235, PMCID: PMC10540659, DOI: 10.1080/2162402x.2023.2260618.
• Parathyroid hormone therapy improves MRSA-infected fracture healing in a murine diabetic modelKwon H, Cahill S, Yu K, Alder K, Dussik C, Jeong J, Back J, Lee F. Parathyroid hormone therapy improves MRSA-infected fracture healing in a murine diabetic model. Frontiers In Cellular And Infection Microbiology 2023, 13: 1230568. PMCID: PMC10565816, DOI: 10.3389/fcimb.2023.1230568.
• Lysine Demethylation in PathogenesisCao J, Yan Q. Lysine Demethylation in Pathogenesis. 2023, 1433: 1-14. PMID: 37751133, DOI: 10.1007/978-3-031-38176-8_1.
• KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the ClinicZhang S, Cao J, Yan Q. KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic. 2023, 1433: 113-137. PMID: 37751138, DOI: 10.1007/978-3-031-38176-8_6.
• ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability controlGao Y, Zimmer J, Vasic R, Liu C, Gbyli R, Zheng S, Patel A, Liu W, Qi Z, Li Y, Nelakanti R, Song Y, Biancon G, Xiao A, Slavoff S, Kibbey R, Flavell R, Simon M, Tebaldi T, Li H, Halene S. ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control. Cell Reports 2023, 42: 113163. PMID: 37742191, DOI: 10.1016/j.celrep.2023.113163.
• The β1-adrenergic receptor links sympathetic nerves to T cell exhaustionGlobig A, Zhao S, Roginsky J, Maltez V, Guiza J, Avina-Ochoa N, Heeg M, Araujo Hoffmann F, Chaudhary O, Wang J, Senturk G, Chen D, O’Connor C, Pfaff S, Germain R, Schalper K, Emu B, Kaech S. The β1-adrenergic receptor links sympathetic nerves to T cell exhaustion. Nature 2023, 1-10. PMID: 37731001, DOI: 10.1038/s41586-023-06568-6.
• Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer statesNyman J, Denize T, Bakouny Z, Labaki C, Titchen B, Bi K, Hari S, Rosenthal J, Mehta N, Jiang B, Sharma B, Felt K, Umeton R, Braun D, Rodig S, Choueiri T, Signoretti S, Van Allen E. Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states. Cell Reports Medicine 2023, 4: 101189. PMID: 37729872, PMCID: PMC10518628, DOI: 10.1016/j.xcrm.2023.101189.
• Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case studyTan S, Aung T, Claeson M, Acs B, Zhou C, Brown S, Lambie D, Baade P, Pandeya N, Soyer H, Smithers B, Whiteman D, Rimm D, Khosrotehrani K. Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study. Journal Of The American Academy Of Dermatology 2023 PMID: 37730017, DOI: 10.1016/j.jaad.2023.09.026.
• International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant TherapyDacic S, Travis W, Redman M, Saqi A, Cooper W, Borczuk A, Chung J, Glass C, Lopez J, Roden A, Sholl L, Weissferdt A, Posadas J, Walker A, Zhu H, Wijeratne M, Connolly C, Wynes M, Bota-Rabassedas N, Sanchez-Espiridion B, Lee J, Berezowska S, Chou T, Kerr K, Nicholson A, Poleri C, Schalper K, Tsao M, Carbone D, Ready N, Cascone T, Heymach J, Sepesi B, Shu C, Rizvi N, Sonett J, Altorki N, Provencio M, Bunn P, Kris M, Belani C, Kelly K, Wistuba I, Committee I. International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy. Journal Of Thoracic Oncology 2023, 18: 1290-1302. PMID: 37702631, DOI: 10.1016/j.jtho.2023.07.017.
• Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti‐glomerular basement membrane diseaseJacobs J, Villalba C, Stendahl K, Tormey C, Abels E. Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti‐glomerular basement membrane disease. Journal Of Clinical Apheresis 2023 PMID: 37698143, DOI: 10.1002/jca.22088.
• Biomarkers and biosensors for early cancer diagnosis, monitoring and prognosisWahab M, Palaniyandi T, Ravi M, viswanathan S, Baskar G, Surendran H, Gangadharan S, Rajendran B. Biomarkers and biosensors for early cancer diagnosis, monitoring and prognosis. Pathology - Research And Practice 2023, 250: 154812. PMID: 37741139, DOI: 10.1016/j.prp.2023.154812.
• IL-6 trans-signaling in a humanized mouse model of sclerodermaOdell I, Agrawal K, Sefik E, Odell A, Caves E, Kirkiles-Smith N, Horsley V, Hinchcliff M, Pober J, Kluger Y, Flavell R. IL-6 trans-signaling in a humanized mouse model of scleroderma. Proceedings Of The National Academy Of Sciences Of The United States Of America 2023, 120: e2306965120. PMID: 37669366, PMCID: PMC10500188, DOI: 10.1073/pnas.2306965120.
• Enhanced mitochondrial buffering prevents Ca2+ overload in naked mole‐rat brainCheng H, Perkins G, Ju S, Kim K, Ellisman M, Pamenter M. Enhanced mitochondrial buffering prevents Ca2+ overload in naked mole‐rat brain. The Journal Of Physiology 2023 PMID: 37668020, DOI: 10.1113/jp285002.
• MKP1 promotes nonalcoholic steatohepatitis by suppressing AMPK activity through LKB1 nuclear retentionQiu B, Lawan A, Xirouchaki C, Yi J, Robert M, Zhang L, Brown W, Fernández-Hernando C, Yang X, Tiganis T, Bennett A. MKP1 promotes nonalcoholic steatohepatitis by suppressing AMPK activity through LKB1 nuclear retention. Nature Communications 2023, 14: 5405. PMID: 37669951, PMCID: PMC10480499, DOI: 10.1038/s41467-023-41145-5.
• The sympathetic nervous system promotes hepatic lymphangiogenesis, which is protective against liver fibrosisTanaka M, Jeong J, Thomas C, Zhang X, Zhang P, Saruwatari J, Kondo R, McConnell M, Utsumi T, Iwakiri Y. The sympathetic nervous system promotes hepatic lymphangiogenesis, which is protective against liver fibrosis. American Journal Of Pathology 2023 PMID: 37673329, DOI: 10.1016/j.ajpath.2023.08.004.
• Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trialMonjazeb A, Daly M, Luxardi G, Maverakis E, Merleev A, Marusina A, Borowsky A, Mirhadi A, Shiao S, Beckett L, Chen S, Eastham D, Li T, Vick L, McGee H, Lara F, Garcia L, Morris L, Canter R, Riess J, Schalper K, Murphy W, Kelly K. Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial. Nature Communications 2023, 14: 5332. PMID: 37658083, PMCID: PMC10474145, DOI: 10.1038/s41467-023-40813-w.
• Immunology for the Rheumatologist: A&R introduces a new problem‐based immunology review series with great educational potentialBucala R, Solomon D. Immunology for the Rheumatologist: A&R introduces a new problem‐based immunology review series with great educational potential. Arthritis & Rheumatology 2023 PMID: 37655656, DOI: 10.1002/art.42688.
• 43437 Ustekinumab for the Treatment of Metastatic Crohn DiseaseMcKay G, Coromilas A, Liu L, Murphy M, Punyamurthy N, Damsky W, Wanat K, Rosenbach M, Caplan A, LaSenna C, Shields B. 43437 Ustekinumab for the Treatment of Metastatic Crohn Disease. Journal Of The American Academy Of Dermatology 2023, 89: ab103. DOI: 10.1016/j.jaad.2023.07.414.
• 44140 Obsessive-Compulsive Disorder Among Patients with Atopic Dermatitis: A Case-Control Study in the All of Us Research ProgramChen G, Fan R, Leasure A, Damsky W, Cohen J. 44140 Obsessive-Compulsive Disorder Among Patients with Atopic Dermatitis: A Case-Control Study in the All of Us Research Program. Journal Of The American Academy Of Dermatology 2023, 89: ab69. DOI: 10.1016/j.jaad.2023.07.279.
• Pharmacological effect of gold nanoparticles from red algae Halymenia venusta on A549 cell lineBaskar G, Palaniyandi T, Viswanathan S, Wahab M, Surendran H, Ravi M, Rajendran B, Govindasamy G, Sivaji A, Kaliamoorthy S. Pharmacological effect of gold nanoparticles from red algae Halymenia venusta on A549 cell line. Inorganic Chemistry Communications 2023, 155: 111005. DOI: 10.1016/j.inoche.2023.111005.
• Classification of Breast Cancer According to ERBB2 Immunohistochemistry ScoresRobbins C, Fernandez A, Rimm D. Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores. JAMA Oncology 2023, 9: 1298-1299. PMID: 37498606, DOI: 10.1001/jamaoncol.2023.2635.
• Intraductal Oncocytic Papillary Neoplasm and Intraductal Tubulopapillary Neoplasm: Cytomorphology and Ancillary Testing of Uncommon High-Grade Pancreatic NeoplasmsSardana R, Burke O, Gilani S, Stendahl K, Muniraj T, Aslanian H, Cai G. Intraductal Oncocytic Papillary Neoplasm and Intraductal Tubulopapillary Neoplasm: Cytomorphology and Ancillary Testing of Uncommon High-Grade Pancreatic Neoplasms. Journal Of The American Society Of Cytopathology 2023, 12: s46. DOI: 10.1016/j.jasc.2023.07.081.
• Fine-Needle Aspiration Differential Diagnosis of Pancreatic Solid Pseudopapillary Neoplasm and Pancreatic Neuroendocrine Tumor: An Immunocytochemical StudyBurke O, Sardana R, Wang M, Stendahl K, Adeniran A, Cai G. Fine-Needle Aspiration Differential Diagnosis of Pancreatic Solid Pseudopapillary Neoplasm and Pancreatic Neuroendocrine Tumor: An Immunocytochemical Study. Journal Of The American Society Of Cytopathology 2023, 12: s46. DOI: 10.1016/j.jasc.2023.07.082.
• Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemiaLi X, Lozovatsky L, Tommasini S, Fretz J, Finberg K. Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia. Blood Advances 2023, 7: 5156-5171. PMID: 37417950, PMCID: PMC10480544, DOI: 10.1182/bloodadvances.2022009524.
• Persistent oral ulcers in a woman with thymomaLockwood N, Bhullar S, Panse G, Leventhal J. Persistent oral ulcers in a woman with thymoma. JAAD Case Reports 2023, 41: 40-43. PMID: 37842161, PMCID: PMC10568229, DOI: 10.1016/j.jdcr.2023.08.015.
• Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammationPekayvaz K, Gold C, Hoseinpour P, Engel A, Martinez-Navarro A, Eivers L, Coletti R, Joppich M, Dionísio F, Kaiser R, Tomas L, Janjic A, Knott M, Mehari F, Polewka V, Kirschner M, Boda A, Nicolai L, Schulz H, Titova A, Kilani B, Lorenz M, Fingerle-Rowson G, Bucala R, Enard W, Zimmer R, Weber C, Libby P, Schulz C, Massberg S, Stark K. Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation. Immunity 2023 PMID: 37652021, DOI: 10.1016/j.immuni.2023.08.002.
• Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic NeoplasmsLabaki C, Al-Choueiry M, Nyman J, Hou Y, Bi K, Zhang L, Hobeika C, Bakouny Z, Priolo C, Khabibullin D, Schindler N, Fu J, Camp S, Saliby R, Saad E, Van Allen E, Shukla S, Henske E, Choueiri T, Braun D. Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic Neoplasms. The Oncologist 2023, 28: s7-s8. PMCID: PMC10445568, DOI: 10.1093/oncolo/oyad216.011.
• Host immune signatures as predictors of response to immunotherapy-based regimens in patients with metastatic renal cell carcinoma (mRCC)Saad E, Labaki C, Saliby R, Bakouny Z, Song L, Wall M, Pan W, Semaan K, Eid M, Gwo-Shu M, Braun D, Liu X, Choueiri T. Host immune signatures as predictors of response to immunotherapy-based regimens in patients with metastatic renal cell carcinoma (mRCC). The Oncologist 2023, 28: s4-s5. PMCID: PMC10445570, DOI: 10.1093/oncolo/oyad216.007.
• Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinomaSaliby R, Zarif T, Bakouny Z, Shah V, Xie W, Flippot R, Denize T, Kane M, Madsen K, Ficial M, Hirsch L, Wei X, Steinharter J, Harshman L, Vaishampayan U, Severgnini M, McDermott D, Lee G, Xu W, Van Allen E, McGregor B, Signoretti S, Choueiri T, McKay R, Braun D. Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma. The Oncologist 2023, 28: s15-s16. PMCID: PMC10445571, DOI: 10.1093/oncolo/oyad216.026.
• Lichen Nitidus: A Case of Tiny, Shiny, Skin BumpsKimball K, Damsky W, Richmond J. Lichen Nitidus: A Case of Tiny, Shiny, Skin Bumps. Frontiers For Young Minds 2023, 11: 1033760. DOI: 10.3389/frym.2023.1033760.
• HIF-1 regulates pathogenic cytotoxic T cells in lupus skin diseaseLittle A, Chen P, Vesely M, Khan R, Fiedler J, Garritano J, Islam F, McNiff J, Craft J. HIF-1 regulates pathogenic cytotoxic T cells in lupus skin disease. JCI Insight 2023, 8 PMID: 37526979, DOI: 10.1172/jci.insight.166076.
• An optimized visualization and quantitative protocol for in-depth evaluation of lymphatic vessel architecture in the liverJeong J, Tanaka M, Yang Y, Arefyev N, DiRito J, Tietjen G, Zhang X, McConnell M, Utsumi T, Iwakiri Y. An optimized visualization and quantitative protocol for in-depth evaluation of lymphatic vessel architecture in the liver. AJP Gastrointestinal And Liver Physiology 2023, 325: g379-g390. PMID: 37605828, DOI: 10.1152/ajpgi.00139.2023.
• Updates in classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium of MDS (icMDS)Stahl M, Bewersdorf J, Xie Z, Porta M, Komrokji R, Xu M, Abdel-Wahab O, Taylor J, Steensma D, Starczynowski D, Sekeres M, Sanz G, Sallman D, Roboz G, Platzbecker U, Patnaik M, Padron E, Odenike O, Nimer S, Nazha A, Majeti R, Loghavi S, Little R, List A, Kim T, Hourigan C, Hasserjian R, Halene S, Griffiths E, Gore S, Greenberg P, Figueroa M, Fenaux P, Efficace F, DeZern A, Daver N, Churpek J, Carraway H, Buckstein R, Brunner A, Boultwood J, Borate U, Bejar R, Bennett J, Wei A, Santini V, Savona M, Zeidan A. Updates in classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium of MDS (icMDS). Blood Reviews 2023, 101128. PMID: 37704469, DOI: 10.1016/j.blre.2023.101128.
• Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapyBiswas S, Kang K, Ng K, Radivoyevitch T, Schalper K, Zhang H, Lindner D, Thomas A, MacPherson D, Gastman B, Schrump D, Wong K, Velcheti V, Saunthararajah Y. Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy. Cell Reports 2023, 42: 113016. PMID: 37597186, PMCID: PMC10528072, DOI: 10.1016/j.celrep.2023.113016.
• Roles for diacylglycerol in synaptic vesicle priming and release revealed by complete reconstitution of core protein machinerySundaram R, Chatterjee A, Bera M, Grushin K, Panda A, Li F, Coleman J, Lee S, Ramakrishnan S, Ernst A, Gupta K, Rothman J, Krishnakumar S. Roles for diacylglycerol in synaptic vesicle priming and release revealed by complete reconstitution of core protein machinery. Proceedings Of The National Academy Of Sciences Of The United States Of America 2023, 120: e2309516120. PMID: 37590407, PMCID: PMC10450444, DOI: 10.1073/pnas.2309516120.
• A Risk-Prediction Platform for Acute Kidney Injury and 30-Day Readmission After Colorectal Surgery.Nellis JR, Sun Z, Chang B, Della Porta G, Mantyh CR. A Risk-Prediction Platform for Acute Kidney Injury and 30-Day Readmission After Colorectal Surgery. J Surg Res 2023, 292: 91-96. PMID: 37597454, DOI: 10.1016/j.jss.2023.07.040.
• Hypophosphatemic rickets: An unexplained early feature of craniometaphyseal dysplasiaBarros J, Braddock D, Carpenter T. Hypophosphatemic rickets: An unexplained early feature of craniometaphyseal dysplasia. Bone Reports 2023, 19: 101707. PMID: 37654679, PMCID: PMC10466911, DOI: 10.1016/j.bonr.2023.101707.
• Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastasesSchoenfeld D, Moutafi M, Martinez S, Djureinovic D, Merkin R, Adeniran A, Braun D, Signoretti S, Choueiri T, Parisi F, Hurwitz M, Rimm D, Wei W, Jilaveanu L, Kluger H. Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases. Journal For ImmunoTherapy Of Cancer 2023, 11: e007240. PMID: 37586773, PMCID: PMC10432651, DOI: 10.1136/jitc-2023-007240.
• Proceedings of the Association for Pathology Informatics Bootcamp 2022Obstfeld A, Brodsky V, Carter A, Gershkovich P, Haymond S, Levy B, Sinard J, Sellers D, Stoffel M, Jackups R. Proceedings of the Association for Pathology Informatics Bootcamp 2022. Journal Of Pathology Informatics 2023, 14: 100331. PMID: 37705688, PMCID: PMC10495674, DOI: 10.1016/j.jpi.2023.100331.
• Abstract A013: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinomaBraun D, Keskin D, Shukla S, McGregor B, Schindler N, Blass E, Klaeger S, Pomerance L, Sarkizova S, Li S, Southard J, Moranzoni G, Pedersen C, Liu Y, Chang S, Hirsch M, LeBoeuf N, Mossanen M, Chea V, Carulli I, Olive O, Mehndiratta A, Greenslade H, Oliveira G, Iorgulescu J, Signoretti S, Aster J, Elagina L, Leshchiner I, Getz G, Harden M, Gabriel S, Olsen L, Neuberg D, Fritsch E, Hacohen N, Livak K, Carr S, Ott P, Wu C, Choueiri T. Abstract A013: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma. Cancer Research 2023, 83: a013-a013. DOI: 10.1158/1538-7445.kidney23-a013.
• Abstract B013: T cell clonotype expansion is common in advanced renal cell carcinoma but is not associated with altered response to PD-1 blockadeHugaboom M, Ruthen N, Jegede O, Schindler N, Wirth L, Kyrysyuk S, McDermott D, Plimack E, Sosman J, Haas N, Hurwitz M, Hammers H, Signoretti S, Atkins M, Wu C, Braun D, Street K. Abstract B013: T cell clonotype expansion is common in advanced renal cell carcinoma but is not associated with altered response to PD-1 blockade. Cancer Research 2023, 83: b013-b013. DOI: 10.1158/1538-7445.kidney23-b013.
• Abstract A029: Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation of renal cell carcinoma (RCC)Semaan K, Zarif T, Eid M, Shah V, Fortunato B, Saliby R, Nassar A, Alaiwi S, Seo J, Labaki C, Bakouny Z, Matar S, Ahmar N, Laimon Y, Lee G, Pomerantz M, Berchuck J, Signoretti S, Van Allen E, Choueiri T, Braun D, Freedman M, Baca S. Abstract A029: Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation of renal cell carcinoma (RCC). Cancer Research 2023, 83: a029-a029. DOI: 10.1158/1538-7445.kidney23-a029.
• Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune microenvironmentAlchoueiry M, Labaki C, Zhang L, Hou Y, Bi K, Hobeika C, Wells J, Takemura K, Bakouny Z, Camp S, Priolo C, Khabibullin D, Schindler N, Saliby R, Saad E, Salem S, Daou M, McKay R, Pal S, Heng D, Van Allen E, Shukla S, Choueiri T, Braun D, Henske E. Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune microenvironment. Cancer Research 2023, 83: b019-b019. DOI: 10.1158/1538-7445.kidney23-b019.
• Abstract PR015: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinomaBraun D, Keskin D, Shukla S, McGregor B, Schindler N, Blass E, Klaeger S, Pomerance L, Sarkizova S, Li S, Southard J, Moranzoni G, Pedersen C, Liu Y, Chang S, Hirsch M, LeBoeuf N, Mossanen M, Chea V, Carulli I, Olive O, Mehndiratta A, Greenslade H, Oliveira G, Iorgulescu J, Signoretti S, Aster J, Elagina L, Leshchiner I, Getz G, Harden M, Gabriel S, Olsen L, Neuberg D, Fritsch E, Hacohen N, Livak K, Carr S, Ott P, Wu C, Choueiri T. Abstract PR015: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma. Cancer Research 2023, 83: pr015-pr015. DOI: 10.1158/1538-7445.kidney23-pr015.
• PRAME‐negativity in sclerosing nevi with pseudomelanomatous features supports classification as an indolent lesionTang H, McNiff J, Glusac E, Ko C. PRAME‐negativity in sclerosing nevi with pseudomelanomatous features supports classification as an indolent lesion. Journal Of Cutaneous Pathology 2023 PMID: 37565491, DOI: 10.1111/cup.14505.
• Current Clinical Practices and Challenges in Molecular Testing: A GOAL Consortium Hematopathology Working Group ReportLee T, Aisner D, David M, David M, Eno C, Gagan J, Gocke C, Guseva N, Haley L, Jajosky A, Jones D, Mansukhani M, Mroz P, Murray S, Newsom K, Paulson V, Paulson V, Roy S, Rushton C, Segal J, Senaratne T, Siddon A, Starostik P, Van Ziffle J, Wu D, Xian R, Yohe S, Kim A. Current Clinical Practices and Challenges in Molecular Testing: A GOAL Consortium Hematopathology Working Group Report. Blood Advances 2023, 7: 4599-4607. PMID: 37236162, PMCID: PMC10425685, DOI: 10.1182/bloodadvances.2023010149.
• Antigenic targets in clear cell renal cell carcinomaSchindler N, Braun D. Antigenic targets in clear cell renal cell carcinoma. Kidney Cancer 2023, 7: 81-91. PMCID: PMC10475986, DOI: 10.3233/kca-230006.
• Infectious neutrophil deployment is regulated by resolvin D4.Libreros S, Nshimiyimana R, Lee B, Serhan CN. Infectious neutrophil deployment is regulated by resolvin D4. Blood 2023, 142: 589-606. PMID: 37295018, DOI: 10.1182/blood.2022019145.
• Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease PathogenesisHwang E, Abdelghaffar M, Shields B, Damsky W. Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis. JID Innovations 2023, 3: 100220. PMID: 37719661, PMCID: PMC10500476, DOI: 10.1016/j.xjidi.2023.100220.
• Phase II window study of olaparib alone or with cisplatin or durvalumab in operable Head and Neck CancerMoutafi M, Koliou G, Papaxoinis G, Economopoulou P, Kotsantis I, Gkotzamanidou M, Anastasiou M, Pectasides D, Kyrodimos E, Delides A, Giotakis E, Papadimitriou N, Panayiotides I, Perisanidis C, Fernandez A, Xirou V, Poulios C, Gagari E, Yaghoobi V, Gavrielatou N, Shafi S, Aung T, Kougioumtzopoulou A, Kouloulias V, Palialexis K, Gkolfinopoulos S, Strati A, Lianidou E, Fountzilas G, Rimm D, Foukas P, Psyrri A. Phase II window study of olaparib alone or with cisplatin or durvalumab in operable Head and Neck Cancer. Cancer Research Communications 2023, 3: 1514-1523. PMID: 37575280, PMCID: PMC10414130, DOI: 10.1158/2767-9764.crc-23-0051.
• Humanized mouse liver reveals endothelial control of essential hepatic metabolic functionsKaffe E, Roulis M, Zhao J, Qu R, Sefik E, Mirza H, Zhou J, Zheng Y, Charkoftaki G, Vasiliou V, Vatner D, Mehal W, AlcHepNet, Kluger Y, Flavell R. Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions. Cell 2023, 186: 3793-3809.e26. PMID: 37562401, DOI: 10.1016/j.cell.2023.07.017.
• Helicobacter pylori-negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach : A clinicopathologic analysis.Gu S, Siddon A, Huntington S, Jain D. Helicobacter pylori-negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach : A clinicopathologic analysis. American Journal Of Clinical Pathology 2023 PMID: 37556379, DOI: 10.1093/ajcp/aqad088.
• Platinum Sensitivity in IDH1/2 Mutated Intrahepatic Cholangiocarcinoma: Not All “BRCAness” Is Created EqualDoroshow D, Wei W, Mehrotra M, Sia D, Eder J, Bindra R, Houldsworth J, LoRusso P, Walther Z. Platinum Sensitivity in IDH1/2 Mutated Intrahepatic Cholangiocarcinoma: Not All “BRCAness” Is Created Equal. Cancer Investigation 2023, 41: 646-655. PMID: 37505929, DOI: 10.1080/07357907.2023.2242957.
• IGHV allele similarity clustering improves genotype inference from adaptive immune receptor repertoire sequencing dataPeres A, Lees W, Rodriguez O, Lee N, Polak P, Hope R, Kedmi M, Collins A, Ohlin M, Kleinstein S, Watson C, Yaari G. IGHV allele similarity clustering improves genotype inference from adaptive immune receptor repertoire sequencing data. Nucleic Acids Research 2023, 51: e86-e86. PMID: 37548401, PMCID: PMC10484671, DOI: 10.1093/nar/gkad603.
• Postinfantile Giant Cell Hepatitis in Native and Allograft Livers: A Multi-Institutional Clinicopathologic Study of 70 Cases.Jiao J, Chezar K, Zhang X, Wang D, Cao W, Bindu C, Chen W, Neto AG, Henn P, Riahi I, Wang HL, Papke DJ Jr, Zhao L, Xue Y, Liao X, Zhang X. Postinfantile Giant Cell Hepatitis in Native and Allograft Livers: A Multi-Institutional Clinicopathologic Study of 70 Cases. Mod Pathol 2023, 36: 100298. PMID: 37544363, DOI: 10.1016/j.modpat.2023.100298.
• BSBM-16 HLA CLASS-I ANTIGEN PRESENTATION MACHINERY AND IFN-γ PATHWAY ALTERATIONS IN LUNG CANCER BRAIN METASTASESVilarino N, de Rodas M, Lu B, Goldberg S, Schalper K. BSBM-16 HLA CLASS-I ANTIGEN PRESENTATION MACHINERY AND IFN-γ PATHWAY ALTERATIONS IN LUNG CANCER BRAIN METASTASES. Neuro-Oncology Advances 2023, 5: iii4-iii4. PMCID: PMC10402438, DOI: 10.1093/noajnl/vdad070.012.
• Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancerde Miguel F, Gentile C, Feng W, Silva S, Sankar A, Exposito F, Cai W, Melnick M, Robles-Oteiza C, Hinkley M, Tsai J, Hartley A, Wei J, Wurtz A, Li F, Toki M, Rimm D, Homer R, Wilen C, Xiao A, Qi J, Yan Q, Nguyen D, Jänne P, Kadoch C, Politi K. Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer. Cancer Cell 2023, 41: 1516-1534.e9. PMID: 37541244, DOI: 10.1016/j.ccell.2023.07.005.
• Utility of parathyroid hormone immunocytochemistry in fine needle aspiration diagnosis of parathyroid tissueSardana R, Abi‐Raad R, Adeniran A, Cai G. Utility of parathyroid hormone immunocytochemistry in fine needle aspiration diagnosis of parathyroid tissue. Cytopathology 2023 PMID: 37534757, DOI: 10.1111/cyt.13283.
• Chromophobe renal cell carcinomaHenske E, Cheng L, Hakimi A, Choueiri T, Braun D. Chromophobe renal cell carcinoma. Cancer Cell 2023, 41: 1383-1388. PMID: 37541245, DOI: 10.1016/j.ccell.2023.07.006.
• Genetics of Diffuse Idiopathic Skeletal Hyperostosis and Ossification of the Spinal LigamentsKato H, Braddock D, Ito N. Genetics of Diffuse Idiopathic Skeletal Hyperostosis and Ossification of the Spinal Ligaments. Current Osteoporosis Reports 2023, 21: 552-566. PMID: 37530996, DOI: 10.1007/s11914-023-00814-6.
• P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE INHIBITOR ENTINOSTAT + PEMBROLIZUMAB IN MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA REFRACTORY TO HYPOMETHYLATING AGENTSBewersdorf J, Shallis R, Sharon E, Caldwell A, Wei W, Yacoub A, Madanat Y, Zeidner J, Altman J, Odenike O, Yerrabothala S, Kovacsovics T, Podoltsev N, Halene S, Little R, Pierkarz R, Gore S, Kim T, Zeidan A. P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE INHIBITOR ENTINOSTAT + PEMBROLIZUMAB IN MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA REFRACTORY TO HYPOMETHYLATING AGENTS. HemaSphere 2023, 7: e30347e2. PMCID: PMC10428733, DOI: 10.1097/01.hs9.0000969884.30347.e2.
• P1385: DISTINCT RATES OF ICANS BUT SIMILAR CYTOKINE SIGNATURES BETWEEN TWO CD19-CAR T CELL THERAPIES: LISOCABTAGENE MARALEUCEL AND AXICABTAGENE CILOLEUCELRasheed Y, Mirza A, Pine A, Hamouche R, Leveille E, Goshua G, Gu S, Liu Y, Vanoudenhove J, Bar N, Neparidze N, Foss F, Gowda L, Isufi I, Halene S, Lee A, Seropian S. P1385: DISTINCT RATES OF ICANS BUT SIMILAR CYTOKINE SIGNATURES BETWEEN TWO CD19-CAR T CELL THERAPIES: LISOCABTAGENE MARALEUCEL AND AXICABTAGENE CILOLEUCEL. HemaSphere 2023, 7: e19857ae. PMCID: PMC10430478, DOI: 10.1097/01.hs9.0000972428.19857.ae.
• P1381: DISTINCT CYTOKINE SIGNATURES OF IDECABTAGENE VICLEUCEL COMPARED TO AXICABTAGENE CILEUCEL AND LISOCABTAGENE MARALEUCELMirza A, Pine A, Hamouche R, Rasheed Y, Leveille E, Goshua G, Gu S, Liu Y, Vanoudenhove J, Bar N, Neparidze N, Foss F, Gowda L, Isufi I, Halene S, Lee A, Seropian S. P1381: DISTINCT CYTOKINE SIGNATURES OF IDECABTAGENE VICLEUCEL COMPARED TO AXICABTAGENE CILEUCEL AND LISOCABTAGENE MARALEUCEL. HemaSphere 2023, 7: e1847498. PMCID: PMC10430598, DOI: 10.1097/01.hs9.0000972412.18474.98.
• Molecular Techniques and Gene Mutations in Myelodysplastic SyndromesMendoza H, Siddon A. Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes. Clinics In Laboratory Medicine 2023 DOI: 10.1016/j.cll.2023.06.002.
• Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53Siddon A, Weinberg O. Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53. Clinics In Laboratory Medicine 2023 DOI: 10.1016/j.cll.2023.07.004.
• Advances in Myelodysplastic SyndromesSiddon A. Advances in Myelodysplastic Syndromes. Clinics In Laboratory Medicine 2023 DOI: 10.1016/j.cll.2023.08.015.
• Impact of COVID-19 on the gastrointestinal surgical oncology patient populationBakkila B, Bakkila B, Marks V, Marks V, Kerekes D, Kunstman J, Kunstman J, Salem R, Salem R, Billingsley K, Ahuja N, Ahuja N, Laurans M, Laurans M, Olino K, Olino K, Khan S. Impact of COVID-19 on the gastrointestinal surgical oncology patient population. Heliyon 2023, 9: e18459. DOI: 10.1016/j.heliyon.2023.e18459.
• A Broad-Host-Range Phage Cocktail Selectively and Effectively Eliminates Vibrio Species from Shrimp Aquaculture Environment.Lomelí-Ortega CO, Barajas-Sandoval DR, Martínez-Villalobos JM, Jaramillo CR, Chávez EM, Gómez-Gil B, Balcázar JL, Quiroz-Guzmán E. A Broad-Host-Range Phage Cocktail Selectively and Effectively Eliminates Vibrio Species from Shrimp Aquaculture Environment. Microb Ecol 2023, 86: 1443-1446. PMID: 36194291, DOI: 10.1007/s00248-022-02118-1.
• The effect of burosumab on intact and C-terminal FGF23 measurements.Ashrafzadeh-Kian SL, Ito N, Srivastava T, Garg U, Kato H, Algeciras-Schimnich A, Bornhorst JA. The effect of burosumab on intact and C-terminal FGF23 measurements. Clin Endocrinol (Oxf) 2023, 99: 152-157. PMID: 36263608, DOI: 10.1111/cen.14832.
• Predictive overfitting in immunological applications: Pitfalls and solutionsGygi J, Kleinstein S, Guan L. Predictive overfitting in immunological applications: Pitfalls and solutions. Human Vaccines & Immunotherapeutics 2023, 19: 2251830. PMID: 37697867, PMCID: PMC10498807, DOI: 10.1080/21645515.2023.2251830.
• The Promise of Epigenetics Research in the Treatment of Appendiceal NeoplasmsLadel L, Tan W, Jeyakanthan T, Sailo B, Sharma A, Ahuja N. The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms. Cells 2023, 12: 1962. PMID: 37566041, PMCID: PMC10417136, DOI: 10.3390/cells12151962.
• Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part I. Epidemiology, Pathogenesis, Clinicopathological Features, and Prognosis.Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part I. Epidemiology, Pathogenesis, Clinicopathological Features, and Prognosis. Journal Of The American Academy Of Dermatology 2023 PMID: 37516359, DOI: 10.1016/j.jaad.2023.02.072.
• Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part II. Diagnosis and Management.Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part II. Diagnosis and Management. Journal Of The American Academy Of Dermatology 2023 PMID: 37516356, DOI: 10.1016/j.jaad.2023.02.073.